SEC Form 4 · accession 0001209191-18-007406
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Philip D Gregory
Officer — Chief Scientific Officer
Period of report
Feb 1, 2018
Accepted (ET)
Feb 5, 2018 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2018 | A | 8,500 | $0.00 | A | 32,272 | D | |
| Common Stock | Feb 1, 2018 | M | 1,250 | $50.51 | A | 33,522 | D | |
| Common StockF3 | Feb 1, 2018 | S | 301 | $202.5349 | D | 33,221 | D | |
| Common StockF4 | Feb 1, 2018 | S | 400 | $203.725 | D | 32,821 | D | |
| Common StockF5 | Feb 1, 2018 | S | 800 | $205.225 | D | 32,021 | D | |
| Common StockF6 | Feb 1, 2018 | S | 749 | $206.1235 | D | 31,272 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $205.25 | Feb 1, 2018 | A | 34,000 | A | — | Feb 1, 2028 | Common Stock | 34,000 | 34,000 | D |
| Stock Option (right to buy)F8 | $50.51 | Feb 1, 2018 | M | 1,250 | D | — | Mar 1, 2026 | Common Stock | 1,250 | 19,500 | D |
Explanation of responses
- F1Restricted stock units for common stock vest over a four-year period at a rate of 25% on 01/04/2019, 25% on 01/04/2020, 25% on 01/04/2021, and 25% on 01/04/2022.
- F2This sales reported in the Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 17, 2017.
- F3The range in prices for the transaction reported on this line was $202.20 to $203.15. The average weighted price was $202.5349. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $203.25 to $204.05. The average weighted price was $203.7250. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- F5The range in prices for the transaction reported on this line was $204.80 to $205.65. The average weighted price was $205.2250. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- F6The range in prices for the transaction reported on this line was $205.85 to $206.40. The average weighted price was $206.1235. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- F7This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2019, and in 36 equal monthly installments.
- F8This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017 and in 36 equal monthly installments thereafter.